Saba Labs is an innovative biotechnology company developing groundbreaking, cost effective wound care products.  Chronic wounds affect millions of patients around the world – the indirect result of compromised immune systems, limited mobility, infection, aging, and other factors that limit patients’ healing capacity.  The cost burden placed on healthcare systems around the world due to treatment and cascading complications from chronic wounds is tremendous, thought to be in excess of $25 billion annually for the U.S. alone.  Our aim is to confront this drain on resources and hindrance to patient quality of life with wound care products based on simple, cost effective, yet innovative solutions.